Source: PloS one [PLoS One] 2024 Sep 26; Vol. 19 (9), pp. e0310915. Date of Electronic Publication: 2024 Sep 26 (Print Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Diagnostic potential of serum HSP90 beta for HNSCC and its therapeutic prognosis after local hyperthermia therapy.

Authors : Shetake, Neena G.^1,2 (AUTHOR); Kumar, Amit^1,2 (AUTHOR); Huilgol, Nagraj³ (AUTHOR)

Subjects: *THERMOTHERAPY; *HEAT shock proteins; *RECEIVER operating characteristic curves

Source: PLoS ONE. 11/9/2023, Vol. 18 Issue 11, p1-10. 10p.

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Evaluation of Hsp90 and mTOR inhibitors as potential drugs for the treatment of TSC1/TSC2 deficient cancer.

Authors : Mrozek EM; Cancer Genetics Lab, Pulmonary Medicine Division, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, United States of America.; Bajaj V

Subjects: HSP90 Heat-Shock Proteins/HSP90 Heat-Shock Proteins/HSP90 Heat-Shock Proteins/*antagonists & inhibitors ; Neoplasms/Neoplasms/Neoplasms/*drug therapy ; TOR Serine-Threonine Kinases/TOR Serine-Threonine Kinases/TOR Serine-Threonine Kinases/*antagonists & inhibitors

Source: PloS one [PLoS One] 2021 Apr 23; Vol. 16 (4), pp. e0248380. Date of Electronic Publication: 2021 Apr 23 (Print Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Involvement of YAP, TAZ and HSP90 in contact guidance and intercellular junction formation in corneal epithelial cells.

Authors : Raghunathan, Vijay Krishna; Dreier, Britta; Morgan, Joshua T

Subjects: Cornea; Intercellular Junctions; Epithelial Cells

Source: PloS one. 9(10)

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Diagnostic potential of serum HSP90 beta for HNSCC and its therapeutic prognosis after local hyperthermia therapy.

Authors : Neena G Shetake; Amit Kumar; Nagraj Huilgol

Subjects: Medicine; Science

Source: PLoS ONE, Vol 18, Iss 11, p e0281919 (2023)

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Hsp90 Inhibitors Exhibit Resistance-Free Antiviral Activity against Respiratory Syncytial Virus

Authors : Geller, Ron; Andino, Raul; Frydman, Judith

Subjects: Infectious Diseases; Pediatric; Immunization

Source: PLOS ONE. 8(2)

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Multi-drug loaded micelles delivering chemotherapy and targeted therapies directed against HSP90 and the PI3K/AKT/mTOR pathway in prostate cancer.

Authors : Le B; Division of Pharmaceutical Sciences, School of Pharmacy, University of Wisconsin-Madison, Madison, Wisconsin, United States of America.; Powers GL

Subjects: Micelles* ; Phosphoinositide-3 Kinase Inhibitors*; Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/*pharmacology

Source: PloS one [PLoS One] 2017 Mar 28; Vol. 12 (3), pp. e0174658. Date of Electronic Publication: 2017 Mar 28 (Print Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Retraction: Bcl-2 Regulates HIF-1α Protein Stabilization in Hypoxic Melanoma Cells via the Molecular Chaperone HSP90

Authors : The Editors

Subjects: Medicine; Science

Source: PLoS ONE, Vol 17, Iss 5 (2022)

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Evaluation of Hsp90 and mTOR inhibitors as potential drugs for the treatment of TSC1/TSC2 deficient cancer.

Authors : Evelyn M Mrozek; Vineeta Bajaj; Yanan Guo

Subjects: Medicine; Science

Source: PLoS ONE, Vol 16, Iss 4, p e0248380 (2021)

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Client Proteins and Small Molecule Inhibitors Display Distinct Binding Preferences for Constitutive and Stress-Induced HSP90 Isoforms and Their Conformationally Restricted Mutants.

Authors : Prince TL; Urologic Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, United States of America.; Kijima T

Subjects: Mutation*; Benzoquinones/Benzoquinones/Benzoquinones/*pharmacology ; HSP90 Heat-Shock Proteins/HSP90 Heat-Shock Proteins/HSP90 Heat-Shock Proteins/*chemistry

Source: PloS one [PLoS One] 2015 Oct 30; Vol. 10 (10), pp. e0141786. Date of Electronic Publication: 2015 Oct 30 (Print Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

نتائج البحث

فلترة النتائج

The heat shock protein 90 inhibitor RGRN-305 attenuates SARS-CoV-2 spike protein-induced inflammation in vitro but lacks effectiveness as COVID-19 treatment in mice.

Diagnostic potential of serum HSP90 beta for HNSCC and its therapeutic prognosis after local hyperthermia therapy.

Evaluation of Hsp90 and mTOR inhibitors as potential drugs for the treatment of TSC1/TSC2 deficient cancer.

Involvement of YAP, TAZ and HSP90 in contact guidance and intercellular junction formation in corneal epithelial cells.

Diagnostic potential of serum HSP90 beta for HNSCC and its therapeutic prognosis after local hyperthermia therapy.

Hsp90 Inhibitors Exhibit Resistance-Free Antiviral Activity against Respiratory Syncytial Virus

Multi-drug loaded micelles delivering chemotherapy and targeted therapies directed against HSP90 and the PI3K/AKT/mTOR pathway in prostate cancer.

Retraction: Bcl-2 Regulates HIF-1α Protein Stabilization in Hypoxic Melanoma Cells via the Molecular Chaperone HSP90

Evaluation of Hsp90 and mTOR inhibitors as potential drugs for the treatment of TSC1/TSC2 deficient cancer.

Client Proteins and Small Molecule Inhibitors Display Distinct Binding Preferences for Constitutive and Stress-Induced HSP90 Isoforms and Their Conformationally Restricted Mutants.

اتصل بنا

اتبع